![]() |
Volumn 47, Issue 1, 1999, Pages 15-25
|
Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers
|
Author keywords
Methacrylate copolymers; Pharmaceutical technology; Solid dosage forms
|
Indexed keywords
ACETYLSALICYLIC ACID;
ACYLGLYCEROL;
AMINOPHYLLINE;
BISACODYL;
CHLORPHENIRAMINE MALEATE;
CITRIC ACID;
CITRIC ACID TRIETHYL ESTER;
COPOLYMER;
DICLOFENAC;
ERYTHROMYCIN;
ETHAMBUTOL;
EUDRAGIT;
EUDRAGIT E 100;
EUDRAGIT RS;
GELATIN;
HORMONE;
IBUPROFEN;
ISONIAZID;
KAOLIN;
MESALAZINE;
METHYLENE BLUE;
MINERAL;
PARACETAMOL;
PHENYLPROPANOLAMINE;
PLACEBO;
PLASTICIZER;
POLYMETHACRYLIC ACID DERIVATIVE;
POTASSIUM CHLORIDE;
PREDNISOLONE;
PROPRANOLOL;
QUINIDINE SULFATE;
SPIRAMYCIN;
THEOPHYLLINE;
TRIMEBUTINE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
DIFFERENTIAL SCANNING CALORIMETRY;
DRUG COATING;
DRUG DOSAGE FORM;
DRUG FORMULATION;
DRUG IMPURITY;
DRUG INTERACTION;
DRUG PACKAGING;
DRUG STABILITY;
ENTERIC COATED TABLET;
GARLIC;
HUMIDITY;
SHORT SURVEY;
STORAGE;
TEMPERATURE;
|
EID: 0033018174
PISSN: 09396411
EISSN: None
Source Type: Journal
DOI: 10.1016/S0939-6411(98)00083-6 Document Type: Review |
Times cited : (80)
|
References (9)
|